Literature DB >> 7213515

Enhanced drug metabolism and renal dysfunction.

I Németh, T Szeleczki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213515      PMCID: PMC1401684          DOI: 10.1111/j.1365-2125.1981.tb01109.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

2.  Metabolism of d-glucuronolactone in mammalian systems. Identification of d-glucaric acid as a normal constituent of urine.

Authors:  C A Marsh
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

3.  Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.

Authors:  J Hunter; J D Maxwell; M Carrella; D A Stewart; R Williams
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

4.  Urinary D-glucaric acid assay by an improved enzymatic procedure.

Authors:  C J Simmons; M Davis; B Dordoni; R Williams
Journal:  Clin Chim Acta       Date:  1974-02-28       Impact factor: 3.786

5.  Genetic control of drug levels in man: antipyrine.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-07-05       Impact factor: 47.728

6.  The plasma half-life of antipyrine in chromic uraemic and normal subjects.

Authors:  J L Maddocks; C J Wake; M J Harber
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

7.  Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?

Authors:  M L Aitio; T Vuorenmaa
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

  7 in total
  3 in total

1.  Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.

Authors:  J van Harten; J Burggraaf; P van Brummelen; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

2.  Antipyrine metabolite formation and excretion in patients with chronic renal failure.

Authors:  M W Teunissen; D Kampf; I Roots; N P Vermeulen; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Metabolism of amitriptyline in patients with chronic renal failure.

Authors:  M Sandoz; S Vandel; B Vandel; B Bonin; B Hory; Y St Hillier; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.